New Paradigms in Allergy, Asthma and Immunology: From Augmented Intelligence, Exposomes to Precision Medicine

Welcome Message

Dear Friends and Colleagues,

Allergic diseases and asthma are rapidly growing health problems worldwide with a marked socio-economic impact. Alongside rapid environmental and lifestyle changes, the fast-evolving economies in Asia-Pacific face an increasing burden of allergic diseases. Advances in science, epidemiology, epigenetics, innovation, and technology continually challenge countries in the post-pandemic world. The Asia Pacific Association of Allergy, Asthma, and Clinical Immunology (APAAACI) together with the Malaysian Society of Allergy and Immunology (MSAI) will host the APAAACI 2024 Congress from the 12th – 15th December 2024 in Kuala Lumpur, Malaysia.

The scientific program is being developed as a well-woven combination of cutting edge advances and practical clinical aspects in allergy, asthma, and clinical immunology, addressing the needs of both clinicians and researchers across specialties working in this space. With key international, regional, and national opinion leaders, this will be a truly unique platform for leaders, colleagues, and junior members to share knowledge, network, and interact for the best scientific exchange and future collaborations. We hope the Congress will provide a unique platform as a knowledge base in the treatment and prevention of Allergies, Asthma, and Immunologic Disease.

On behalf of the APAAACI and MSAI, we welcome our industry partners to be part of this Congress. Your support will play an integral part in making the Congress a scientifically rewarding event for all those who participate. Together we can make a difference to the community at large.

Let’s make the APAAACI 2024 Congress a success! We look forward to your active participation!



Prof. Jiu Yao Wang
Congress Chair



Prof. Ruby Pawankar
Congress Chair



Prof. Kent Woo Chee Keen
Congress Co-Chair

Key Topics

  • Atopic dermatitis, urticaria, severe cutaneous adverse reactions ( SJS, TENS), skin allergy mimics
  • HAE, Drug allergy, Vaccine allergy, Occupational allergy, Insect sting allergies
  • Autoinflammatory diseases, Immunodeficiencies, Inborn errors of immunity
  • Food allergy, Anaphylaxis, Oral immunotherapy, Nutrition, Allergy prevention, Dietary interventions, Prebiotics/ probiotics
  • Severe asthma, ACOS, Eosinophil-related diseases
  • Allergic rhinitis, Chronic rhinosinusitis with nasal polyposis, Phenotypes and endotypes
  • Paediatric allergies/ asthma, COVID, emerging pathogens, vaccinology
  • Biologics, Personalized Medicine and future therapies, Biomarkers in allergic diseases
  • Immunotherapy, Immune tolerance, Immune regulation, Desensitization
  • Environment, Climate change, Air pollution, Biodiversity , Aerobiology, Microbiome, Epithelial barrier and immune disease, Non-communicable diseases, Epigenetics
  • Basic and clinical immunology, Single cell technology, Tools for translational research
  • Digital technologies in allergy care, Allergy and Immunology practice in Asia-Pacific

Important Dates

01 March 2024

Abstract Submission Opens

20 March 2024

Early Bird Registration Opens

31 July 2024

Abstract Submission Deadline

30 August 2024

Abstract Submission Notification

1 October 2024

Early Bird Registration Deadline


Prof. Jiu Yao Wang

Congress Chair

Prof. Ruby Pawankar

Congress Chair

Prof. Kent Woo Chee Keen

Congress Co-Chair

Prof. Amir Hamzah Abdul Latiff

Congress Vice-Chair

Prof. Dr. Salina Hussain

Congress Vice-Chair

Subscribe To Our Newsletter


Our specialty is evolving. Allergic diseases and asthma are a rapidly growing health problem worldwide with a marked socio-economic impact. Alongside the rapid environmental (climate change, pollution, etc) and lifestyle changes, the fast-evolving economies of Asia-Pacific face the major brunt of the burden of allergic diseases.